Hologic (HOLX)There is some room for this to run longer until earnings in February. If it breaks above this ceiling, upside potential into $103. The stock has good potential and good ratings on both Zacks and Weiss.
HOLX trade ideas
Buy Signal: 74.33Stop: 70.50
Model signaling a continuation trade toward 80. Below 70.50 the current up wave would be invalidated.
Potential continuation?Holx looks like it might be headed toward all time highs if this upwave holds. Would be invalidated if price falls below 67.
Ingenuity Trading Model is an algorithm used in- Stock, Forex, Futures, and Crypto markets. The model is a Geometric Markov Model : Focuses on reversal and continuation wave structures
In probability theory, a Markov model is a stochastic model used to predict randomly changing systems. Markov Models are used in all aspects of life from Google search to daily weather forecast. The randomly changing systems we focus on are the equity, futures, and forex markets. The geometric element of the model is the fractal sine wave structure you can find on any chart you look at across any market and across all time dimensions.
Our model focuses on the current sine wave formation (current state)- geometric price formation along with its volume and volatility over a given time period and using that information to predict the future state- future price movement. For questions or more information feel free to contact me in the comment section or via private chat
$HOLX Correction Pattern$HOLX
Testing Correction Pattern theory: Bull Pennant with support. In theory this is ready to bounce – fib trend would suggest 1.27 is at $75.
“I’m not an expert but I have watched a lot of youtube videos.”
NASDAQ:HOLX
HOLX - November 29, 2020Hologic Inc. is a developer, manufacturer and supplier of diagnostic and medical imaging systems primarily dedicated to serving the healthcare needs of women. HOLX’s EPS is projected to grow 59.8% this year, crushing the industry average of 9.6%. With the succession of outperforming competition and profit levels surging, HOLX will continue on a favourable trend this quarter.
HOLXNice consolidation here. Break above and test of ATH is possible. Beware of where overall market is at the moment and its upcoming earrings. (No position)
$holx raised guid big for Q , off 9ema now$holx raised guid big for Q last week in poor market , off 9ema pullback now. Hurt like many off ABT 5 buckeroo test.. guidance after shows matters nothing.
Pull Back Fishing C&H Long when fall is complete
Substantial pullback involving a strong stock. Usually not volatile. Hit first target and major pull back/sell off occurred.
Possible support at top trend line of ascending triangle or at handle low. Has fallen through support at recent gap up
Holx was also in a rising wedge before break out from A Triangle.
Those rising wedges seem to always catch up with you eventually )o: Long when fall is complete. Rising wedges are usually bearish at the top and can indicate a pull back or a reversal. I do not like them. When selling starts there is a lack of buyers; Too many buyers inside the rising wedge and a lack of healthy pull backs can cause a rising wedge. Boils down to supply and demand
Just an observation as I have owned this for a long time.
V Cup and HandleBroke out of C&H and has gone down to fill gap left behind.
I own this but do not recommend it
In the past this has been a slow but steady mover without a lot of volatility.
Only thing that never changes is change though (o:
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, surgical products, and light-based aesthetic and medical treatment systems for women in the United States and internationally. The company offers Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for acute respiratory ailments. It also provides breast imaging and analytics, such as 2D and 3D mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company offers aesthetic treatment systems, as well as TempSure, a radio frequency energy-sourced platform, which offers non-surgical and surgical aesthetic treatments and procedures. Further, it offers NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Additionally, the company offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
My HOLOGIC OpinionHello traders, HOLOGIC is very interesting we are in the highest history, attempt of the repressed sellers with the largest volume of purchase in the session. It is located on a strong trend support in a stabilization zone, great potential to breakout the consolidation zone to enter another to seek a new higher.
Please LIKE & FOLLOW, thank you!
Hologic, Inc. On Covid 19 Watch-list post CNBC SlotThe FDA has granted Emergency Use Authorization for Hologic's (NASDAQ:HOLX) Panter Fusion SARS-CoV-2 assay, a molecular diagnostic test that detects the coronavirus causing the current outbreak COVID-19.
The company says the automated Panther Fusion system can process up to 1,150 tests in a 24-hour period (~383 test/eight-hour shift).
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following business segments: Breast Health, Diagnostics, Medical Aesthetics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a broad portfolio of breast imaging and related products and accessories, including digital mammography systems, computer-aided detection, for mammography and minimally invasive breast biopsy devices, breast biopsy site markers, and breast biopsy guidance systems. The Diagnostics segment comprises Aptima family of Assays, target capture/nucleic acid extraction techonolgy, transcription-mediated amplification technology, hybridization protection assay and dual kinetic assat technologies, instrumentation, and Invader Chemistry Platform. The Medical Aesthetics segment offers SculpSure; PicoSure, MedLite, and RevLite; and MonaLisa Touch. The GYN Surgical segment encompasses the NovaSure Endometrial Ablation System and the MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment covers the discovery and horizon X-ray bone densitometry system, an ultrasound-based osteoporosis assessment product, and Fluoroscan mini C-arm imaging products. The company was founded by S. David Ellenbogen and Jay A. Stein in 1986 and is headquartered in Marlborough, MA
HOLX - GameplanHOLX is very strong and close to highs creating a flag pattern
go long on break above resistance or bounce at support
targets are resistance levels
Clayton, Dubilier & Rice to Acquire Market-Leading Medical AesthHOLX: Clayton, Dubilier & Rice
2019-11-20 07:30:00
Clayton, Dubilier & Rice to Acquire Market-Leading Medical Aesthetics Technology Company
Hologic $HOLX breakout triggered Friday afternoonHOLX has some size in April OTM calls and 2570 of the June $50 calls as well
HOLX MonthlyHOLX monthly moving out of long sideways range, like to see RSI clear this trend, March $48 OTM call buyers today NASDAQ:HOLX
[HOLX] phase 1The risk/reward is 3.08. I think the price will go down (3.96% vs 12.18%) If the price breaks the support, it will be in phase 4.
